Speaker:
Hanna Park


Learning Objectives:

• Describe Alzheimer’s disease (AD), focusing on history, pathophysiology, and available treatment options
• Analyze the literature supporting efficacy and safety of amyloid targeted therapies (ATT), including lecanemab and donanemab, in AD
• Apply learned clinical concepts about AD to develop treatment recommendations for patient cases

Disclosure:
Hanna Park has no relevant financial relationships to disclose.